014 United-Amedisys

The Health Care Market Oversight (HCMO) program reviews health care business deals, like mergers and acquisitions, to make sure they won’t harm people and communities in Oregon. 

This transaction is currenlty undergoing comprehensive review. OHA has requested more information from the entities. The review period id currently paused until the entities provide the requested information. The Health Care Market Oversight (HCMO) program reviews health care business deals, like mergers and acquisitions, to make sure they won’t harm people and communities in Oregon. 

OHA has published the following reports and communications to date:

• Determination Letter
• Preliminary Review Report
  
• Transaction Summary
  

Filings and Submissions

• Notice of Material Change Transaction
• Appendix A: Answers to HCMO Notice
• Appendix B: Provider identifiers and addresses
• Appendix C: Home health and hospice locations
  
• Appendix D: Merger Agreement
• Appendix E: Redaction Log
• Appendix F: February 2, 2024 Supplemental Responses

One Page Transaction Summary

Public Comments

OHA is accepting public comments throughout the review period. To submit a public comment about this transaction, please email hcmo.info@oha.oregon.gov and include the word "Amedisys" in the subject line of your message.

• Compiled Email Public Comments 
  
• Public Comment from John Santa
  

Questions?

Please email: hcmo.info@oha.oregon.gov

Media inquiries:
Erica Heartquist, Communications
erica.j.heartquist@oha.oregon.gov
(503) 871-8843